Considering the introduction of universal MRSA screening

Journal of Hospital Infection

Volumn 69, Issue 4, 2008, Pages 315-320

  Dancer, S J ^a  

^a HAIRMYRES HOSPITAL   (United Kingdom)

Author keywords

MRSA; Resources; Universal screening

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; LINEZOLID; POLYPEPTIDE ANTIBIOTIC AGENT; VANCOMYCIN;

BACTERIAL COLONIZATION; BACTERIAL TRANSMISSION; DRUG BLOOD LEVEL; DRUG CHOICE; EDITORIAL; HEALTH CARE FACILITY; HOSPITAL PERSONNEL MANAGEMENT; HUMAN; INFECTION CONTROL; LABORATORY TEST; MEDICAL ETHICS; MEDICAL STAFF; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIOLOGICAL EXAMINATION; PATIENT CARE; PATIENT COUNSELING; RESOURCE MANAGEMENT; SENSITIVITY AND SPECIFICITY; STAPHYLOCOCCUS INFECTION; WORKING TIME;

CARRIER STATE; CROSS INFECTION; ENVIRONMENTAL MICROBIOLOGY; HUMANS; INFECTION CONTROL; METHICILLIN RESISTANCE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 47749154387     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhin.2008.05.002     Document Type: Editorial

References (39)

1. Muto C.A., Jernigan J.A., Ostrowsky B.E., et al. SHEA guideline for preventing nosocomial transmission of multi-drug-resistant strains of Staphylococcus aureus and Enterococcus. Infect Control Hosp Epidemiol 24 (2003) 362-386
2. Siegel J.D., Rhinehart E., Jackson M., Chiarello L., and Healthcare Infection Control Practices Advisory Committee. Management of multidrug-resistant organisms in healthcare settings, 2006. Am J Infect Control 35 Suppl. 2 (2007) S165-S193
3. Robicsek A., Beaumont J.L., Paule S.M., et al. Universal surveillance for methicillin-resistant Staphylococcus aureus in 3 affiliated hospitals. Ann Intern Med 148 (2008) 409-418
4. Farr B. Political versus epidemiological correctness. Infect Control Hosp Epidemiol 28 (2007) 589-593
5. Weber S.G., Huang S.S., Oriola S., et al. Legislative mandates for use of active surveillance cultures to screen for methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: position statement from the Joint SHEA and APIC Task Force. Am J Infect Control 35 (2007) 73-85
6. Diekema D.J., and Edmond M.B. Look before you leap: active surveillance for multidrug-resistant organisms. Clin Infect Dis 44 (2007) 1101-1107
7. Strausbaugh L.J., Siegel J.D., and Weinstein R.A. Preventing transmission of multidrug-resistant bacteria in health care settings: a tale of 2 guidelines. Clin Infect Dis 42 (2006) 828-835
8. Muto C.A., Jarvis W.R., and Farr B.M. Another tale of two guidelines. Clin Infect Dis 43 (2006) 796-797
9. Strausbaugh LJ, Siegel JD, Weinstein RA. Reply to Muto, et al. Clin Infect Dis 2006;43:797-798.
10. Harbarth S., Fankhauser C., Schrenzel J., et al. Universal screening for methicillin-resistant Staphylococcus aureus at hospital admission and nosocomial infection in surgical patients. J Am Med Assoc 299 (2008) 1149-1157
11. Jeyaratnam D., Whitty C.J.M., Phillips K., et al. Impact of rapid screening tests on acquisition of meticillin-resistant Staphylococcus aureus: cluster randomised crossover trial. BMJ 336 (2008) 927-930
12. Edmond MB, Ober JF, Bearman G. Active surveillance cultures are not required to control MRSA infections in the critical care setting. Am J Infect Control, in press.
13. Papia G., Louie M., Tralla A., et al. Screening high-risk patients for methicillin-resistant Staphylococcus aureus on admission to the hospital: is it cost effective?. Infect Control Hosp Epidemiol 20 (1999) 473-477
14. Kuonori T., Cookson B., Roberts J.A., Stone S., and Kibbler C. Cost-effectiveness of different MRSA screening methods. J Hosp Infect 51 (2002) 189-200
15. Conterno L.O., Shymanski J., Ramotar K., et al. Real-time polymerase chain reaction detection of methicillin-resistant Staphylococcus aureus: impact on nosocomial transmission and costs. Infect Control Hosp Epidemiol 28 (2007) 1134-1141
16. Desjardins M., Guibord C., Lalonde B., Toye B., and Ramotar K. Evaluation of the IDI-MRSA assay for detection of methicillin-resistant Staphylococcus aureus from nasal and rectal specimens pooled in a selective broth. J Clin Microbiol 44 (2006) 1219-1223
17. Lines L. A study of senior staff nurses' perceptions about MRSA. Nurs Times 102 (2006) 32-35
18. Dancer S.J. The effect of antibiotics on MRSA. J Antimicrob Chemother 61 (2008) 246-253
19. Kanerva M., Blom M., Tuominen U., et al. Costs of an outbreak of meticillin-resistant Staphylococcus aureus. J Hosp Infect 66 (2007) 22-28
20. Dancer S.J., and Simmons N. MRSA behind bars?. J Hosp Infect 62 (2006) 261-263
21. Humphreys H. Can we do better in controlling and preventing methicillin-resistant Staphylococcus aureus (MRSA) in the intensive care unit (ICU)?. Eur J Clin Microbiol Infect Dis 27 (2008) 409-413
22. Tarzi S., Kennedy P., Stone S., and Evans M. Methicillin-resistant Staphylococcus aureus: psychological impact of hospitalisation and isolation in an older adult population. J Hosp Infect 49 (2001) 250-254
23. Vasquez J.E., Walker E.S., Franzus B.W., et al. The epidemiology of mupirocin resistance among methicillin-resistant Staphylococcus aureus at a Veterans' affairs hospital. Infect Control Hosp Epidemiol 21 (2000) 459-464
24. Orrett F.A. The emergence of mupirocin resistance among clinical isolates of methicillin-resistant Staphylococcus aureus in Trinidad: a first report. Jpn J Infect Dis 61 (2008) 107-110
25. Dancer S.J. Glycopeptide resistance in Staphylococcus aureus. J Antimicrob Chemother 51 (2003) 1309-1311
26. Kernodle D.S., Classen D.C., Stratton D.W., and Kaiser A.B. Association of borderline oxacillin-susceptible strains of Staphylococcus aureus with surgical wound infections. J Clin Microbiol 36 (1998) 219-222
27. Dancer SJ. The real cost of MRSA. Chapter 16:281-309. In: Gould IM, van der Meer JWM, editors. Antibiotic policies: theory and practice. New York: Kluwer/Plenum; 2005.
28. Lautenbach E. Expanding the universe of methicillin-resistant Staphylococcus aureus prevention. Ann Intern Med 148 (2008) 474-476
29. Millar M., Coast J., and Ashcroft R. Are MRSA bloodstream infection targets fair to those with other types of healthcare associated infection or cost effective?. J Hosp Infect 69 (2008) 1-5
30. Duerden B. Opinion on Millar, et al. J Hosp Infect 2008;69:6-7.
31. Millar M. Response to Duerden. J Hosp Infect 69 (2008) 89
32. Merle V., Van Rossem V., Tavolacci M.P., and Czernichow P. Knowledge and opinions of surgical patients regarding nosocomial infections. J Hosp Infect 60 (2005) 169-171
33. Ben-David D., Mermel L.A., and Parenteau S. Methicillin-resistant Staphylococcus aureus transmission: the possible importance of unrecognised health care worker carriage. Am J Infect Control 36 (2008) 93-97
34. Sherertz R.J., Bassetti S., and Bassetti-Wyss B. 'Cloud' health-care workers. Emerg Infect Dis 7 (2001) 241-244
35. Guinan J.L., McGuckin M., Shubin A., and Tighe J. A descriptive view of malpractice claims for health care-acquired infections in Philadelphia. Am J Infect Control 33 (2005) 310-312
36. Robicsek A., Suseno M., Beaumont J.L., Thomson Jr. R.B., and Peterson L.R. Prediction of methicillin-resistant Staphylococcus aureus involvement in disease sites by concomitant nasal sampling. J Clin Microbiol 46 (2008) 588-592
37. Manian F.A., Meyer P.L., Setzer J., and Senkel D. Surgical site infections associated with methicillin-resistant Staphylococcus aureus: do postoperative factors play a role?. Clin Infect Dis 36 (2003) 863-868
38. Jeyeratman D., Edgeworth J.D., and French G.L. Enhanced surveillance of meticillin-resistant Staphylococcus aureus bacteraemia in a London teaching hospital. J Hosp Infect 63 (2006) 365-373
39. Tacconelli E. Methicillin-resistant Staphylococcus aureus: risk assessment and infection control policies. Clin Microbiol Infect 14 (2008) 407-410